WTx-Bortezomib Program (Window Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameWTx-Bortezomib Program (Window Therapeutics)
Drug Alias NamePolymer based prodrug of bortezomib (Window Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWindow Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWindow Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A